This site is intended for Healthcare Professionals only

Maxwellia

overactive bladder, summary.jpg

Mixed reaction to proposed oxybutynin POM to P switch

Some pharmacists have criticised a proposal to reclassify the drug for overactive bladder in women.

25 Apr 2022

Change privacy settings